Precigen(PGEN) - 2023 Q4 - Annual Results

Exhibit 99.1 Precigen Reports Full Year 2023 Financial Results and Business Updates GERMANTOWN, MD, March 19, 2024 – Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced full year 2023 financial results and business updates. "2024 is poised to be a transformative year for Precigen, as we are on track to present pivotal Phase 2 data in the second quarter and submit a BLA for PRGN-2012 ...